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malice are used in the analysis of bl01o3ical systems. Usually these algorithm 
are computatior41ly very intensive and r~;lulro high-end w0ri~tatio~ or e~ 
percomputers. Our goal was to achieve comparable performance on ~ low 
ceat PC l~atiom~ 
Implemanlafion: Asan exempt, we l~lemenled ~ slmcfund cOrrq~exBy 
measure e, a parameter used for su~en cardiac death prediction and im- 
age processing. The software is a mullflhmeded esign, utilizing symmetric 
muittprocesStng,with up to 32 CPUs if available, It adapts ~elf to a wide va- 
rtety of WlN3~ op~rettng envtronm~t~ 0N~ndows 95 to Mu l t i~r  R1SC 
systems). It features the familiar Wir~owe t~ser interface ~ minimal ~41nlng 
IS required to use It. 
Verification: The te~ng and the evaluation of performs;ca were done 
using 69 hoiter datasete, ~ was calculated on a Crey sW!ercomputer, a HP 
Workstation cluster and on uur PC system (Dual Pentium 90 Mhz CPUS), 
Average time per dataset was 0.5 rain on the C~y, 7 min on the HI:', 17 m~n 
using one Pentlum end 9 rain using b~th CPUs on our test system. Estimated 
time for a 32 CPU system is 0,75 rain. The resulting ~ valtms were Identical 
for all platforms. 
Conclusion: Using our Implementation approach, performance comparable 
to workstations or even SupemomputerS can be achieved on PC systems for 
nonlinear dynamics algorithms. 
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~ Pm.lnfMction Angina Is Not Auoctated  With Htgh 
Risk CiinlP~i Chsraeteristiss In Patients With s First 
Non-Q-Wave Myocardial Infarction 
Avanlndra Jaln, Robert A. O'Rourke, William E. Boden, for the VANQWlSH 
Inves!igeiom. U~K TX. Hlth. Sci. Cntr., San Antonio, TX 
Prior sludtea of non-Q.wave myocan~al Infarction (MI) have identtf~l pre- 
intar~--tlon a gina as an important predictor el !ong-tarm clinfcal outcome, but 
have not consisted antecedent angina with non-invasive and invealve find. 
ings of myocardial ischemla, left ventdcular function, or corone~y anatomy. VA 
Non.Q-Wave Infarction Strategies In-Hospital (VANQWlSH) is a prospective 
randomized study to c-~.~'~oara consewattve strategy (radtonucliOe ventricu- 
logrsphy and exe¢ise thallium) ve invastve strategy (cardiac catheterization) 
in patients with non-Q-wave ML Aocordlngly, we compared the baseline flnd~ 
in0s in 400 patients with a first non-Q-w~ve MI on the basis of the presence 
or absence of pre-intar~ion angina (within 3 weeks before MI). 
Hx Angh~e # pts EF High Rtsk 1"1 El'r+ LM~VCAD 
Yes 181 50% 30% 29% 3Q% 
No 239 52% 24% 25% 33% 
p value NS NS NS NS 
Ejection fracHon - El-. High risk thallium ('n) - rr,ultL~one Is hemla or thallium lung 0ptake, 
El-r+ = posiltve xercise Im~aclrnllli(mt LM- ~1 main. CAD - coronary ~rtexy dteea,e,a. 
Thus, the Presence of pre-lnfarction angina is not ~sociated with a dif- 
ference in left ventricular function, the InOdence or severity of Inducible 
myocardial isshemia, or the extent of coronary artery disease In patients with 
a first non-CF.wave myocardial infarction. 
4:15 
Primary A nglopisM]( Leads to a Low Incidence of 
Adverse uutcumes in Patients With the Substrata 
for Right Ventrlculsr Infarction 
Ten~ R. Beware, William W. O'Neill, James A. Gol¢istaln, Bruce Bro~e, 
John Gdffin, Bp,,an Donohue, C. Costantial, Caries Balastrln~, Denise 
E. Jones, Cindy L. Grines, William Beaumont Hospital, Royal Oak, MI 
Impairment of right ventrlcular performance complicating inferior myocardial 
infarction (IMI) has been reported to 0¢cur in up to 50% of patients (pts) 
with proximal right coronary artery (RCA) occlusion and result in high rates 
of hamedynamio compromise and death, However, these reports Involve a 
small number of pts who dld not receive mgeffusion therapy, Accordingly, to 
determine if proximal RCA occlusions are associated with adveme clinical 
outcomes, we corrq~md clinical end ~gingrapllio chera0tarlsttc~ In 640 IM1 
pte who undemmnt a~te catheterization and PdmaW PTCA~ RCA ~c~uston 
prior to the first acute marginal branch In 190 pts (Group !) was cOmpared to 
more distal RCA end (droumflex occlusion tn 450 patients (Group II), Anglo- 
graphic assessment revealed no significant differences hap#sen the groups 
with regard to ejection fraction, extent of multivesasl dies&as, PTCA suc- 
cess, and TIMI 3 flow. Although pts with proximal RCA occlusions had more 
fraquent bmdyan~mias, there was a ~nsplc~m~ absence of hemody- 
namio d~er~s  between the groups. Transient or sustained episodes of 
hyPotension, and the need for vasoprassom were similar. In.hospital out- 
comes including death, recurrent MI, reocctusion, ven~c~Jlar arrhythmias 
and congestive heart failure were not significantly ditfsrent: 
D F.ATH R~ Ml ~,TNF SUST (~  
Group I 3.2% 4.2% 6,3% 8.3% 
Group Ii 2.2% 4.2% 5.P/* ~ .;P/~ 
p 0,580 1.000 ~,4i79 O.,ME 
Conc/us/o~}: Pmximol RCA (~-Jusion, the subsk'~;e for RV infarction, ts 
0~Ssec~ted with e low trekler.ce of ~ insl;d~'lify and in.hospltal 
mortality. These data suggest hat hemodyr~lmically s i~ In~ RV intarotion 
occurs more infrequently then previously reported or iv aborted by reperfusion 
therapy with primary PTCA, 
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A©Uts MYocardial lnfe~ ti~,,l in Chronic DislyMs 
Patiems 
Timothy A, Rubtn, Kimbertse A. "l~ielen, Allan J. Collins, Charles A. Herzog. 
Hennupin County Medical Center ~ in~l i s ,  MN 
ischemtc heart disease is ~ leading cause of death in pts with end stage 
renal disease (ESRD), but no published ata exists on the In-hospital mortality 
rate or therapeutic outcome of treatment of acute MI in chronic dialysis pts. 
We identified 91 chronic dialysis pts admitted for acute MI from 1977 to 1994. 
Their mean age was 65 ~. 11 (range 30-86) with 49 men and 42 women. 
Diabetes ~llitus (DM) was the cause of ESRD in 51% and hypertension in 
22%, Sevef,ty-seven pte (aP/o) were on hemedialysis, Thirty*two f 91 pts 
(35%) had transmural MI by ECG or autopsy. MI location was 14 ~terior 
(44%), 17 inferior (53%) and 1 lateral (3%). The overall in-hospital mortality 
was 29% for all pts. There was no significant dflferencs tn age, gender, 
prevalence of DM or LVH, peak creatine kinase or length of hospital stay 
for pta with ~ra l  vs. no~1~ura l  MI. Tal~e 1 centmsts the Clinical 
outcome by type of MI. 
MI ~ n Pe,sk Destine I~e l  Overall 
Kinase (IU) Days Mmtaltly 
Non~zansmura] 59 487 :E 504 t? :E 21 is% 
Tmnsmural 32 694 ~: 63Ei 15~:t7 a,7%" 
Allteflor 14 81 ~ :E 84e 12 ~ 9 
Inferior 17 568 :E 371 17 ~ ~ 47% 
"p < 0.01 vs. nontransmural 
Only 3 pte received acute coronary rep~fualon therapy (1 PTCA, 2 throm- 
bolytic). The optimal treatment of acute MI in dialysis ~ is unknown as these 
pts were excluded from thmmbolytic trials. Our data strongly supports the 
need for a prospective treatment trial of acute MI in dialysis pts. We conoJude 
[hat dialysis pts with acute MI suffer at, unexpectedly Iligh in-hospital death 
rate. 
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~ R I S k  Factors end Outcomes in Patients With 
Ventrlcalar Septal Defects (VSD) Complicating 
Acute MI 
Brian S. Cranshew, Douglas A. Mc~S, Kamn S. Piepar, Neal S. Kletman, 
Nec Vahanian, Christopher B. Granger, Robe~ M. Callff, Eric J. Topoi, for 
the GUSTO-I InvOlute .  Duke, Durham, ND 
To Identify patient characteristics associated with VSD development after MI 
and to assess its effect on outcome, we compared patients in GUSTO-I with 
VSD (n = 121) vs those without (n = 40751). Unlvariate p~m~top~ of VSD 
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in order of importance were older age (VSD-71 vs No VSD-61), anterior MI 
(67% vs 30%), female sex (50% vs 25%), lower weight (70 kg vS 78 ks), and 
hypertension (54% va 38%); all p < 0.001. Patients with VSO more often 
developed shcck (63°/, vs 6%), CHF (63% va 16%), relnfarctiorl (10% vs 
4%), and recum~nt ischemta (35% vs 20%). Compareo with patients treated 
surgically (n = 32), medically treated patients (n = 88) had similar age (72 vs 
71) but more often had antedor MI (69% vs 63%), lower systolic BP (120 vs 
130), higher pulse (82 vs 78), and Kiflip class lfl-lV, ,4°/= v~ 7%) at baseline. 
Condus/ons: Despite reperfusion therapy. VSD after Mt Carries a poor 
prognosis. Patients selected for surgery have hotter outcomes, 
5:00 
Mlkal Regurgitation Following First Myocardial 
Infarction Is an Indlcatior of Poor In-Hospital and 
Long Term Prognosis 
R Khaja, M. Nant, H. Roams, n, B. Rybtcki, S. Borzak, S. Smith, 
H~N. Sepbah, S. Goldstain. Henry Ford Heart and Vascular tnstttute, Detroit, 
MI 
Mifral Regurgitation (MR) following Myocardial InfarCtion (MI) is frequent. 
We proepecflvely studied £'79 pts with first MI by color flow Doppler for MR 
on admission, to document its prevalence and association with in hospi- 
tal and long term adverse cardiac events classified as; death, pulmonary 
congestion/cardiogenic shock (PC/CS), reinfamtion or post intsretlon angina 
(RI/PIA), and van~fcuiar fibrillation or techcycardia (VF/VT). MR was pmserlt 
in 138/279 (50%) of pts and in 158 (57%) 1 yr follow-up was available. PIS 
with MR were older mean age 62 _ 14 vs 57 ~ 13 (P = 0.001), and had a 
higher incidence of infedor Q wave MI 70/201 (7(P/o) vs 57/141 (57%) - P 
= 0.55 compared to pts without MR. In-hospital adverse cardiac events are 
shovm below: 
DEATH PC/CS RI/PIA VFNT OTHER 
MR 7% 24% 37% 9% 56% 
NO MR 2%" 15%= 26%" 9% 42%" 
*P < 0.0S 
Dudng follow-up, death and CHF was significantly higher in pts with MR 
vs those without, 10% vs 3% (P = 0.05) and 15% vs 1% (P = 0.002). RI was 
more commor, in pts without MR 13% vs 4% (P = 0.05). Conclusion: MR is 
common following first ML It is more frequent with advanced age and iniedor 
Q wave infarction. In hospital and late mortality and adverse cardiac events 
are significantly greater in patients who show MR on admission echo doppler 
study. 
5:15 
~ Aq=ute Myocardial Infarction In Young Patients: The 
Stgnglcance of Smoking. Results From the 
GUSTO-1 Trial 
Mark C.G. Hordgan, Dave P. Miller, Christopher Granger, Robert M. Califl. 
Edc J. Topal, for the GUSTO Investigators. Department of Can~*olo;p~, 
Cleveland Clinic Foundation, Cleveland OH 
Patients receiving thrombolytic therapy for myocardial infarction in the GUSTO 
tdal were grouped by age < 40 (n = 1687: 4.1%) or _> 40 years (n = 39259), 
"Young" patients were more often male (88% vs 74°/,,; P < 0.0001), and 
less often hypartenslvs or diabetic (P < 0,0001). More young patients were 
smokers at entry (77% vs 42%; P < 0,0001 )or had family history of coronary 
diseace (56% vs42%; P < 0.0001), Sixteen percent of young patients were 
not white (black 6%, other 10%), while 8% of those aged > 40 were not white 
(black 3%, other 5%); both P < 0.O0Ot. 
W~iL,- time to treatment was similar (3,1 4-1.7 vs 3.1 ± 1.6 hours), young 
patients had greater peak CK levels, Peak CK was higher in smokers from 
both groups (P < 0,0001), however, linear modeling identified an interaction 
between age < 40 and smoking. Smokers < 40 had stgniflCanUy higher peak 
CK levels than older smokers; whereas no age effect was evident among 
non-smokers. 
Peak CK I S.D. 
Peak CK smokers 
Peak CK non.smokers 
Hospital Death (%) 
30-day mortality (%) 
S~ock (%) 
Re.infarction (%) 
Heart Failure (%) 
Age < 40 Age > 40 P,valua 
2313 =t:2314 1916~1014 <0.01 
2461 ± 2446 2033 ± 1942 < 0.001 
1835:1:1728 1834 :E 1711 0.996 
1.1 6.9 < 0,0001 
1.3 7.2 < 0.0001 
2.0 6.1 < 0.0001 
1.7 4.1 < 0.0001 
7.1 16.6 < 0.0001 
While the outcomes in young patients are favorable compared with those of 
older patients, the profile is not without important sequelae. In this group pre- 
cocious coronary athemsctarosls with symptomatic plaque rupture Is strongly 
associated with smoking, and smoking is associated with evidence of more 
extensive myocardial nncrosis, 
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~ STENTIM Rsg iM~ of S~t lng  at Ac . ta  h The French 
Myocardial Infarction 
Jean Pierre Monassler, Joseph Elias, Pierre Meyer, Made Claude Modce, 
Thierry Royer, Alain Cribiar. CH Mulhouse, France 
Coronary slanting was generally contraindicated in acute myocardial infarc- 
tion. The aim of this reglsW is to evaluate the in hospital out come of patients 
undergoing ."~.'onary stsnting in the first 14 days of acute ML From January 
94 to September 95, 340 patients underwent coronary stsnflng within 14 
days of acute MI i~120 French centers. PTCA was performed within 12 hours 
in 134 (40%) patients (group 1) and between day 1 to day 14 in 206 (65%) 
patients (group 2). 
Indications for PTCA were as follow: pdmary PTCA 98/134 (73%), car- 
dtogenis shock 111134 (8.2%), rescue PTCA 25/134 (I~Yo) in ~up 1 and 
recurrence of ischesmia 115/'206 (56°/,,), elective 901206 (44%) in group 2. 
Indications for stenting were as follow: non occlusive dissection 82°/= and 
60%, occlusive dissection 10% and 8.2°/,, elective 7.5% and 32%, respec- 
tively in group 1 and 2. These patientS received 356 stunts (302 PS, 40 
Wiktor, 12 Roubin and 6 AVE). 
Aif these patients were treated with Ticlopidine 250 mg/d and Aepidn 100 
mg/d for I month, continuous IV Hepadn for 72 hours and LMWH for 7 to 14 
days. 
Results: 
Group 1 Group 2 
Procedural success 128/I 34 (95.5%) 200/206 (97%| 
~tent thrombosis 41134 (3%) 3/206 (1.45%) 
F-.mergency CABG 2/134 (1.5%) 2/206 (1%) 
I~eath 2/134 (4.5%) 4/206 (1.9%) 
Conclusion: after these encouraging results of this registry, a randomized 
trial "STENTIM fl" comg.adng PTCA to PTCA + stenting in a~te MI is now 
going on in order to validate this method, 
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One Week and Six Months Angiographic Controls of 
- Coronary Stent Implantation Outing Primary 
Angiopla,,asty for Acute Myocardial infarction 
Christian Spaulding, Khaldoun Ben Hamda, Laurent Roussel, Yenn Chalet, 
Jacques Monsegu, Antoine Py, Romain Cedor, Olivier Tsokanakis, 
Simon Weber. Cochin Hospital, Rend Descartes Universitg Paris, France 
The correction of a suboptimal result or an occlusive dissection during Pd- 
mary Angieplasty for Acute Myocardial Infarction (PAMI) by stent implanta- 
tion remains controversial We therefore performed one week and six months 
anglographlc ontrols in 45 patients with coronary stents implanted udng 
PAMI. 
Methods: A single Palmaz.Sehatz stent was implanted in 45 patients (3~ 
male, mean age 55.1 :t: 18) for suboptimal results (34) or occlusive dtssec. 
lions (11 ) dudng PAMI on the LAD in 31 and the RCA in 14. Mean LV ejection 
fraction was 40 ~ 10%. Slant deployment was optimized using high pressure 
inflations. Rnal slant diameter was 3.6:1:0.3 ram. Angiographio images of 
thrambus were present before stent implantation in 30 nases and after in 3. 
All patients were treated with Ticlopidine (500 rag/day), aepidn (250 rag/day) 
and low molecular weight hepadn (0.1/10 kg b.i.d, for seven days). 
Results: Two patients died of refractory cardioganio shock on day two 
despite a patent stent. Angingraphic ontrols were performed 7 =E 2 days 
after PTCA in the remaining 43. All stents were patent with no visible image 
of thrambus. One patient died at two months of a non cardiac Cause, A six 
month control anglogram was performed in 39 patients and revealed non 
occlusive restenosis in six. Desplte the initial presence of thrambus, no slant 
occlusion was noted on one week and six months angiographic controls. 
Slant implantation during PAMI seems leasable if optimal atent deploye- 
ment can be performed. 
